IL90267A - Enantiomeric glutaramide diuretic agents, process for their preparation and compositions containing them - Google Patents

Enantiomeric glutaramide diuretic agents, process for their preparation and compositions containing them

Info

Publication number
IL90267A
IL90267A IL90267A IL9026789A IL90267A IL 90267 A IL90267 A IL 90267A IL 90267 A IL90267 A IL 90267A IL 9026789 A IL9026789 A IL 9026789A IL 90267 A IL90267 A IL 90267A
Authority
IL
Israel
Prior art keywords
enantiomeric
preparation
compositions containing
diuretic agents
glutaramide
Prior art date
Application number
IL90267A
Other languages
English (en)
Other versions
IL90267A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL90267A0 publication Critical patent/IL90267A0/xx
Publication of IL90267A publication Critical patent/IL90267A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL90267A 1988-05-19 1989-05-11 Enantiomeric glutaramide diuretic agents, process for their preparation and compositions containing them IL90267A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888811873A GB8811873D0 (en) 1988-05-19 1988-05-19 Therapeutic agents

Publications (2)

Publication Number Publication Date
IL90267A0 IL90267A0 (en) 1989-12-15
IL90267A true IL90267A (en) 1993-08-18

Family

ID=10637176

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90267A IL90267A (en) 1988-05-19 1989-05-11 Enantiomeric glutaramide diuretic agents, process for their preparation and compositions containing them

Country Status (29)

Country Link
EP (1) EP0342850B1 (pt)
JP (1) JPH072699B2 (pt)
KR (1) KR920000561B1 (pt)
CN (1) CN1015361B (pt)
AT (1) ATE76399T1 (pt)
AU (1) AU602813B2 (pt)
CA (1) CA1331197C (pt)
CS (1) CS274502B2 (pt)
DD (1) DD283772A5 (pt)
DE (1) DE68901582D1 (pt)
DK (1) DK172032B1 (pt)
EG (1) EG19007A (pt)
ES (1) ES2037418T3 (pt)
FI (1) FI93541C (pt)
GB (1) GB8811873D0 (pt)
GR (1) GR3004968T3 (pt)
HU (1) HU205067B (pt)
IE (1) IE60724B1 (pt)
IL (1) IL90267A (pt)
MX (1) MX16067A (pt)
MY (1) MY104735A (pt)
NO (1) NO173647C (pt)
NZ (1) NZ229186A (pt)
PH (1) PH26740A (pt)
PL (1) PL154813B1 (pt)
PT (1) PT90584B (pt)
SU (1) SU1766251A3 (pt)
YU (1) YU47973B (pt)
ZA (1) ZA893696B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812597D0 (en) * 1988-05-27 1988-06-29 Pfizer Ltd Therapeutic agents
GB8820844D0 (en) * 1988-09-05 1988-10-05 Pfizer Ltd Therapeutic agents
GB9000725D0 (en) * 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
DK0644176T3 (da) * 1993-09-22 1996-02-26 Pfizer Ltd Hydrogenering
US7468390B2 (en) 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
AR057882A1 (es) 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
US8993631B2 (en) 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy
SI2887961T1 (sl) 2012-08-24 2021-08-31 Novartis Ag Zaviralci NEP za zdravljenje bolezni, značilnih po atrialni širitvi ali preoblikovanju
WO2017033128A1 (en) 2015-08-25 2017-03-02 Novartis Ag Biphenyl-substitued 4-amino-butyric acid derivatives and their use in the synthesis of nep inhibitors
US20180311241A1 (en) 2015-10-29 2018-11-01 Cadila Healthcare Limited Pharmaceutical synergistic combination

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880007441A (ko) * 1986-12-11 1988-08-27 알렌 제이.스피겔 스피로-치환된 글루타르아미드 이뇨제

Also Published As

Publication number Publication date
KR920000561B1 (ko) 1992-01-16
CN1015361B (zh) 1992-02-05
GB8811873D0 (en) 1988-06-22
JPH0222256A (ja) 1990-01-25
CA1331197C (en) 1994-08-02
DK240889D0 (da) 1989-05-18
DE68901582D1 (de) 1992-06-25
NO892002D0 (no) 1989-05-18
PH26740A (en) 1992-09-28
CN1037704A (zh) 1989-12-06
NO173647B (no) 1993-10-04
AU3490489A (en) 1989-11-23
ATE76399T1 (de) 1992-06-15
NZ229186A (en) 1990-10-26
EP0342850A1 (en) 1989-11-23
FI892386A0 (fi) 1989-05-18
NO173647C (no) 1994-01-12
JPH072699B2 (ja) 1995-01-18
YU47973B (sh) 1996-08-13
GR3004968T3 (pt) 1993-04-28
MX16067A (es) 1993-10-01
EG19007A (en) 1994-11-30
MY104735A (en) 1994-05-31
IE60724B1 (en) 1994-08-10
FI892386A (fi) 1989-11-20
HUT53596A (en) 1990-11-28
FI93541B (fi) 1995-01-13
DK240889A (da) 1989-11-20
DK172032B1 (da) 1997-09-22
PT90584B (pt) 1994-09-30
SU1766251A3 (ru) 1992-09-30
YU102289A (en) 1991-06-30
CS274502B2 (en) 1991-04-11
ZA893696B (en) 1990-12-28
EP0342850B1 (en) 1992-05-20
ES2037418T3 (es) 1993-06-16
PL279491A1 (en) 1989-11-27
DD283772A5 (de) 1990-10-24
IL90267A0 (en) 1989-12-15
KR900017993A (ko) 1990-12-20
FI93541C (fi) 1995-04-25
AU602813B2 (en) 1990-10-25
IE891613L (en) 1989-11-19
PL154813B1 (en) 1991-09-30
PT90584A (pt) 1989-11-30
HU205067B (en) 1992-03-30
NO892002L (no) 1989-11-20
CS296589A2 (en) 1990-09-12

Similar Documents

Publication Publication Date Title
AU5027393A (en) Benzo-fused lactams
AU643489B2 (en) Antibacterial agents - II
AU6844790A (en) Novel a-nor-steriod-3-carboxylic acid derivatives
EP0614913A3 (en) Dynorphin derivatives.
IL90267A (en) Enantiomeric glutaramide diuretic agents, process for their preparation and compositions containing them
EP0419856A3 (en) Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates
IE873288L (en) Derivatives of bicyclic aminocarboxylic acids.
HUT41960A (en) Insecticide compositions containing 2,6,7-trioxa-bicyclo/2,2,2/octane derivatives as active agents and process for producing the active agents and intermediates
IE891297L (en) Amino acid esters, a process for the preparation thereof,¹pharmaceuticals containing them, and the use thereof
AU5538790A (en) Intermediates for the production of 2,4,5-trifluorbenzoyl fluoride
CA2024964A1 (en) N-azabicyclo{3.3.0]octane amides of aromatic acids
PT80359B (en) (6,11-dihydro-11-oxodibenz<b,e>oxepinyl)pentanoic acids and derivatives a process and intermediates for their preparation and their use as medicaments
AU1917988A (en) New derivatives of pyrethrinoids containing a nitrogenous heterocycle, their process and intermediates of preparation, their use as pesticides and the compositions containing them
FR2611974B1 (fr) Composition de revetement des electrodes d'un parafoudre
EP0338494A3 (de) 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren
EP0338493A3 (de) Tetrahydro-4-phenylimino-3-thiophenessigsäuren

Legal Events

Date Code Title Description
KB Patent renewed
RH1 Patent not in force